drugset / Trial / NCT00223964

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

NCT00223964

Phase 4 Completed 59 enrolled Watson Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

This was a multi-center study in iron-deficient pediatric hemodialysis patients, whose legal guardian had provided signed informed consent and satisfied the inclusion and exclusion criteria.

Timeline

Start
2003-06
Primary completion
2003-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Ferric Gluconate Complex Unknown 1.5 mg/kg
Subject Sodium Ferric Gluconate Complex Unknown 3 mg/kg

Indications